Praveen Singh

Praveen Singh

Director Director DIN 07056046
DIN 07056046 First appointment Mar 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2015
Shareholding value Locked Premium profile

About Praveen Singh

Data last updated:

Praveen Singh has 11 years in corporate governance. Formerly with 1 company, such as Oparin Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 07056046
Primary Designation Director
First Appointment 11 Mar 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Oparin Biotech Private Limited U85191UP2015PTC069475
Director11 Mar 20152015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Oparin Biotech Private Limited
Premium access

Shareholding and investment profile for Praveen Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Praveen Singh

Praveen Singh has 11 years in corporate governance. Formerly with 1 company, such as Oparin Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Praveen Singh is associated with 0 companies as a director.

Praveen Singh has expertise in Technology.

Praveen Singh has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available